Literature DB >> 109240

Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients.

R Norio, M Koskiniemi.   

Abstract

In 107 Finnish patients with progressive myoclonus epilepsy (PME), belonging to 74 families, autosomal recessive inheritance was evident. The sex ratio was 48:51, the corrected proportion of affected sibs being 0.260. Of 68 marriages 15, or 22%, were consanguineous; several of the parents were related and the geographical distribution was of the uneven type typical of young, isolated populations in Finland. The incidence in Finland was estimated to exceed 1:20,000. The clinical picture in the Finnish PME patients was uniform, being identical with that of Unverricht's and Lundborg's patients, but clearly distinct from Lafora disease. The following classification of PME is proposed: (1) PME, Lafora type: onset of grand mal attacks and/or myoclonus around the 15th year of life; rapid and severe mental deterioration, often with psychotic symptoms; short survival; histological finding of Lafora bodies; autosomal recessive inheritance. (2) PME, Unverricht-Lundborg type: onset around the 10th year of life; severity variable, progressive invalidity from myoclonic features associated with mild mental symptoms, time of survival variable, "degenerative" histological changes; autosomal recessive inheritance. (3) Autosomal dominant or otherwise atypical cases of PME. The importance of accurate diagnosis is stressed.

Entities:  

Mesh:

Year:  1979        PMID: 109240     DOI: 10.1111/j.1399-0004.1979.tb01770.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  21 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

Review 2.  Genes and epilepsy.

Authors:  R M Gardiner
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

3.  Ramsay Hunt syndrome: to bury or to praise.

Authors:  S F Berkovic; F Andermann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

Review 4.  Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects.

Authors:  Luis Felipe Mendonça de Siqueira
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

5.  Has Progress Been Made in Progressive Myoclonic Epilepsy (EPM1)?

Authors:  M Scott Perry
Journal:  Epilepsy Curr       Date:  2015 Sep-Oct       Impact factor: 7.500

6.  Progressive myoclonus epilepsy EPM1 locus maps to a 175-kb interval in distal 21q.

Authors:  K Virtaneva; J Miao; A L Träskelin; N Stone; J A Warrington; J Weissenbach; R M Myers; D R Cox; P Sistonen; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

7.  Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).

Authors:  M D Lalioti; M Mirotsou; C Buresi; M C Peitsch; C Rossier; R Ouazzani; M Baldy-Moulinier; A Bottani; A Malafosse; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 8.  Effect of phenytoin on the mental and physical function of patients with Baltic myoclonus epilepsy.

Authors:  M Iivanainen; R Eldridge
Journal:  Ital J Neurol Sci       Date:  1987-08

9.  Sensorimotor, visual, and auditory cortical atrophy in Unverricht-Lundborg disease mapped with cortical thickness analysis.

Authors:  P Koskenkorva; E Niskanen; J Hyppönen; M Könönen; E Mervaala; H Soininen; R Kälviäinen; R Vanninen
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

Review 10.  Molecular background of progressive myoclonus epilepsy.

Authors:  Anna-Elina Lehesjoki
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.